New cross-cutting themes and a disease focus area were added to Feinberg’s research strategy, strengthening the vision for years to come.
Browsing: Will Doss
Northwestern Medicine scientists have discovered a genetic basis for glaucoma symptoms and the impact of other genes in early retinal development.
Two Northwestern Medicine clinical trials investigated drugs to treat patients suffering from vasodilatory shock and respiratory failure, showing promising results.
Northwestern Medicine investigators applied discovery-based proteomics to identify synaptic protein interactions that possibly contribute to autism spectrum disorders.
Patients with advanced neuroendocrine tumors had a similar quality of life while on a newly approved chemotherapy drug, as compared to patients receiving a placebo, according to a Northwestern Medicine study.
Northwestern Medicine scientists have published a paper in Nature Chemical Biology, detailing an innovative use of CRISPR-Cas9 technology that has helped reveal how oxidative stress explains a common herbicide’s link to risk of Parkinson’s.
The Feinberg Physician Assistant Program raised awareness about the profession and celebrated current students and past graduates as part of National PA Week.
Feinberg alumni discussed their careers in biotechnology and pharmaceuticals and highlighted common pitfalls for physicians to avoid when transitioning to working in industry.
A newly discovered gene mutation may increase a patient’s risk of genetic heart disease, presenting a target for therapy or genetic screening down the road.
Two Northwestern Medicine scientists have received NIH Director’s Awards, which fund innovative research with high-impact potential.